720 South Main Street Phoenixville, Pennsylvania



Introducing Vuity

The first and only FDA-approved eye drop to treat presbyopia or age-related near vision, is now available by prescription in pharmacies nationwide.
The new treatment, called VUITY (pilocarpine HCI ophthalmic solution) 1.25% is a once-daily prescription eye drop recently approved by the FDA to treat presbyopia in adults, a common and progressive aye condition that affects millions of Americans. VUITY was shown in clinical studies to improve near and intermediate vision without impacting distance vision.
There were no serious adverse effects observed in participants receiving VUITY. The most common adverse effects occurring at a frequency of greater than 5% were headaches and eye redness.
Presbyopia which affects most adults after age 40 can make seeing or reading up close more challenging. Nearly 128 million Americans or half the US adult population have presbyopia but despite these numbers, the condition is not commonly known by its clinical name.
The most common signs of presbyopia include:
  • Using brighter lighting to read
  • Holding materials at an arm’s length
  • Squinting your eyes
For more information and to see if you are a candidate, schedule an appointment with one of our doctors.

View All Recent Posts